WASL and cancer: We first provided evidence that treatment with ZCL278 of PDAC cells had similar but less powerful effects compared with cytochalasin B, largely by affecting the downstream Arp2/3 complex and N‐WASP, which play critical roles in actin cytoskeleton organization and metastasis in cancer cells.26, 51, 52